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Introduction
Recent years have seen an alarming rise in the incidence of cardiovascular disease (CVD) linked to obesity-related metabolic factors 1 . Epidemiological studies have confirmed a strong association between fat intake, plasma cholesterol levels, and CVD mortality rates [2] [3] [4] [5] . Of particular concern is the incidence of diabetes in obese patients, since diabetes itself carries a substantially elevated CVD risk 6 . One of the strongest independent predictors of CVD is a low level of high-density lipoprotein (HDL) particles and their major protein constituent apolipoprotein A-I (apoA-I) 7, 8 . Besides its critical role in reverse cholesterol transport and cellular cholesterol efflux, apoAI also has anti-inflammatory, antithrombotic, and antioxidant functions that contribute to its well-known anti-atherogenic function [9] [10] [11] [12] . Low circulating HDL and apoA-I levels are also a hallmark of insulin-resistance, a pathological precondition leading to type 2 diabetes (T2D) 11, 13 . It remains unclear, however, whether circulating HDL levels exert an effect on insulin resistance and the development of diabetes.
Several lines of evidence suggest that HDL and apoA-I modulate glucose homeostasis:
Infusions of reconstituted HDL particles have been shown to reduce circulating glucose levels and increase insulin levels in patients with T2D through insulin-dependent and -independent mechanisms 14 . Cell-based assays have confirmed that both HDL components apoA-I and apoA-II increase beta-cell insulin secretion 15 . HDL and apoA-I have been also demonstrated to directly enhance glucose uptake in cultured mouse and human skeletal muscle cells, thus confirming an insulin-independent effect of HDL 14, 16 . Thus, these results show that HDL and apoA-I are enhancing muscular glucose uptake.
In addition to glucose uptake, intracellular glucose metabolism is known to play a pivotal role in the pathogenesis for insulin resistance and diabetes. After entry into the muscle cell, functions that contribute to its well-known anti-atherogenic function [9] [10] [11] [12] . Low cir ir rcu cu ula lat ti ting ng ng H H HDL D DL and apoA-I levels are also a hallmark of insulin-resistance, a pathological precondition leading to y ype pe pe 2 2 2 d d dia ia iabe be bete te tes (T (T T2 2D 2D) 11, 13 . It remains unclear, ho ho how we ever, whether r c c circu ula la lat ti ting HDL levels exert an ef ffe e ect c on insuli lin n re e esi ist st tan an nce ce e a a and nd nd t the he e d d dev ev ve el lopme me ment o o of f dia ab abet etes es s.
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nfusions of r rec ec econ on onst st stit it i ut ut u ed e e H H HDL DL D p p par ar a ti ti ticl c es es es h h hav av ave e e be be b en en en s s sho hown wn wn t to o o re re redu du d ce ce ce c c cir ir ircu cu cula la lati ting ng ng g g glu lu luco co cose levels 4 glucose is oxidized through mitochondrial phosphorylation to ATP as an energy source for cellular metabolism. Glucose is also used to generate glycogen and converted into fat (lipogenesis) for storage and later use as energy 17 . All three metabolic routes have been shown to contribute to the development of diabetes. Firstly, oxidative phosphorylation and ATP synthesis are impaired in skeletal muscle from relatives of patients with T2D strongly suggesting that defects in mitochondrial oxidative metabolism are a primary cause of insulin resistance 18 .
Secondly, dysfunctional muscle glycogen synthesis has been reported to play a dominant role in insulin resistance of diabetic patients 19 . Consistently, defects in insulin-mediated glucose oxidation, glycogen synthesis and storage have been already revealed in skeletal muscle from individuals with normal glucose tolerance but with peripheral insulin resistance 20 underscoring the importance of intramyocellular glucose metabolism as crucial player in the development of insulin resistance. Lastly, an excessive conversion of glucose into lipid due to defects in mitochondrial function, leads to accumulation of intramyocellular triglycerides, which also has been implicated in insulin resistance in several population studies 21 . Although it has been shown that HDL and apoA-I do increase glucose uptake in muscle cells and thus decrease circulating glucose levels, it has not been determined whether HDL and apoA-I also affect intracellular glucose oxidation, glycogen synthesis, and lipogenesis.
In this study, we investigated the requirement for circulating HDL and apoA-I in normal glucose oxidation of skeletal muscle using a genetic loss-and gain of function mouse model. We show that, in the absence of apoA-I, mitochondrial oxidative phosphorylation is reduced in skeletal muscle resulting in increased circulating glucose levels and impaired muscular function.
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Methods
An expanded online-only Methods and Results section is available in the online-only Data Supplement.
Mice
Age-matched male apoA-I deficient (apoA-I ko), human apoA-I transgenic (apoA-I tg), and control (wt) C57/Bl6J mice (The Jackson Laboratories, Bar Harbor, ME) were housed in specific pathogen-free facilities with a 12-hour light/12-hour dark cycle and were fed basal rodent chow Respiration studies in isolated skeletal muscle mitochondria and cultured muscle cells.
After sacrifice, gastrocnemius muscles were harvested and mitochondria were isolated An expanded online-only Methods and Results section is available in the online--o on only ly l D D Dat at ata a a Supplement.
Mi Mice ce ce
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Results

Circulating HDL is required for normal glucose homeostasis
To understand the role of circulating HDL levels in glucose homeostasis, we used a genetic lossand gain-of-function mouse model for apoA-I, the main protein component of HDL. FPLC analysis of apolipoprotein profiles revealed a severely reduced HDL particle concentration in apoA-I deficient mice (apoA-I ko) and a markedly increased HDL particle concentration in human apoA-I overexpressing (apoA-I tg) mice compared to wild-type (wt) controls ( Figure 1A & B). ApoA-I ko mice exhibited increased hepatic triglyceride content compared to wt and apoA-I tg mice ( Figure 1C ). We detected markedly higher fasting glucose and HbA1c levels in chow-fed apoA-I ko mice compared to wt littermates ( Figure 1E and F) . In contrast, apoA-I tg mice had significantly lower fasting glucose levels compared to wt littermates ( Figure 1E ).
Response to intraperitoneal glucose tolerance test (GTT) was impaired in apoA-I ko and improved in apoA-I tg mice compared to wt littermates ( Figure 1D ). These results indicate that circulating HDL levels are important for the efficient clearance of glucose from the circulation.
To find out which tissue is responsible for HDL-mediated improvement of glucose tolerance and whether HDL modulates basal or insulin-mediated uptake of glucose, we Figure 1S ). This analysis revealed a significant decrease of glucose transport in muscles with a high content of glycolytic (white) fibers IIB like the tibialis lateralis anterior (TLA) and the extensor digitorum longus (EDL) muscle of apoA-I ko mice compared to wt and apoA-I tg mice. However, no difference was observed in muscles with a high content of oxidative (red) fibers I and IIA, like the soleus (SOL) or in muscles with a mixed content of IIA and IIB fibers like the gastrocnemius muscle. Since white fibers are far less responsive to insulin than red fibers due to markedly lower protein levels of glucose transporter 4 (GLUT4), the rate-limiting transporter for insulin-mediated glucose uptake 24-26 , we conclude that apoA-I is modulating glucose transport in muscle directly and independently of insulin. Similar glucose transport rates in fat and liver of wt, apoA-I tg and ko mice rule out these tissues as potential mediators for the HDL-mediated effect on glucose metabolism and point to a musclespecific effect of HDL ( Figure 1G ). Assessment of AKT activation after acute insulin injection as a downstream target for insulin signaling revealed that Insulin increased AKT phosphorylation in quadriceps muscle of wt and apoA-I ko mice to the same extent ( Figure 1H ). In contrast, apoA-I tg mice showed markedly enhanced basal AKT phosphorylation (2.7 ± 1 fold over wt and 2.4 ± 0.2 fold over apoA-I ko mice) with no further increase after insulin injection ( Figure 1H ).
These results also point to an insulin-independent effect of HDL on skeletal muscle.
Glycogen levels are an important determinant of exercise capacity 27 and defects in groups, exercised apoA-I ko mice failed to increase glycogen levels to the same extent as wt and apoA-I tg mice ( Figure 1I ). These results suggest that in absence of apoA-I metabolic adaptations to exercise are hampered in skeletal muscle. Since liver glycogen is quantitatively more important than mucle glycogen for endurance capacity in rodents 27-30 we also determined hepatic glycogen content in our mouse groups: Sedentary apoA-I ko mice exhibited markedly increased glycogen levels compared to wt mice. However, upon training glycogen was severely reduced in apoA-I ko mice while it increased in exercised wt and apoA-I tg mice ( Figure 1J ).
Our results indicate that glycogen metabolism is dysfunctional in the absence of apoA-I.
HDL modulates muscle function through an effect on mitochondrial bioenergetics
We characterized body composition and muscle function in our gain-and loss-of-function models. Lean mass was significantly decreased in apoA-I ko mice (Figure 2 A & B) compared to wt littermates and, conversely, slightly increased in apoA-I tg mice. Since loss of lean mass typically reflects altered muscle biology, we next tested for differences in muscular function by determining oxidative capacity of skeletal muscle in endurance tests using mouse treadmills. We found that reduced circulating HDL in apoA-I ko mice correlated with considerably decreased endurance capacity ( Figure 2D ). Our results suggest that circulating HDL and apoA-I play an important role in normal skeletal muscle metabolism and function.
To understand whether HDL and apoA-I can alter mitochondrial function in skeletal muscle in vivo, we analyzed mitochondrial bioenergetics using Seahorse analyzer. In the absence of apoA-I, oxygen consumption rate (OCR) was markedly reduced and ATP synthesis was clearly blunted in mitochondria isolated from gastrocnemius muscle ( Figure 2E ). Elevated HDL was associated with a moderate increase in ATP synthesis ( Figure 2E ). This small enhancement of mitochondrial ATP synthesis was associated with increases in expression of the ATP synthase
We characterized body composition and muscle function in our gain-and loss-o of-f-f-fu fu unc ncti ti tion on on models. Lean mass was significantly decreased in apoA-I ko mice ( y & G). In contrast, no differences in OCR were detected in mitochondria isolated from liver between the different genotypes (supplemental Figure 2S) . These results provide evidence that circulating HDL is required for normal mitochondrial function in skeletal muscle.
HDL and apoA-I directly enhance cellular respiration of glucose in skeletal muscle and prevent age-induced decline of endurance capacity
To address whether the observed effect of HDL on mitochondrial bioenergetics occurs cell autonomously in skeletal muscle, we applied cell-based in vitro assays. Using Seahorse XF24
analyzer we detected that HDL isolated from human subjects increases glycolysis and OCR in murine C2C12 myoblasts in a dose dependent manner ( Figure 3A and B). Subsequently we determined that HDL and apoA-I, but not LDL or phospholipid vesicles, enhanced glycolysis considerably ( Figure 3C ). Our results indicate that HDL and apoA-I directly affect the breakdown of glucose by increasing both components of cellular respiration, glycolysis and mitochondrial oxidative phosphorylation. Thus, the observed effects on cellular respiration are direct and cell autonomous, and are specific to HDL and apoA-I.
Our observations that normal circulating HDL levels are required for proper skeletal muscle function raised the question whether increasing HDL levels above normal circulating HDL concentrations further improve skeletal muscle glucose utilization and muscle function in vivo. We therefore analyzed fasting glucose and lactate levels in mice with normal (wt) and genetically raised HDL levels (apoA-I tg). Consistent with an increase in glucose utilization, we found that physiologically relevant increases in HDL levels correlated strongly with reduced fasting glucose levels compared to wt mice (Fig. 3D) . HDL-induced increases in glycolysis were reflected by higher circulating lactate levels ( Fig. 3E) . To address the question whether raising murine C2C12 myoblasts in a dose dependent manner ( Figure 3A and B). Subse se equ qu uen entl tl tly y y we we we determined that HDL and apoA-I, but not LDL or phospholipid vesicles, enhanced glycolysis co ons ns nsid id ide er erab ab ably ly ly (Fi igu gu gur re 3C). Our results indicate th th that at HDL and apo oA-A A I di di dire re rectly affect the b br rea a akd k own of f g glu lu l c c cose se e b by y y in in inc cr cre ea easi sing ng ng b bot oth h co o om m mpon n ne en nts o of f f ce ce ell lul ula ar r r res spi pi ir ra rat tion on n, gl glyc yc col ol lys ys y is i i a a a d nd nd mi mi ito to toch ch chon ondr dr ria ia ial l ox ox xid d dat ativ iv ve e ph ph p os s sph ph phor or oryl yl ylat ati io on. n. n T T Thu hu hus, s, s t the he he ob b bse e erv rv rved ed ed e e eff ff fec ec cts ts ts o on n n c ce cell ll lul ul u ar ar a r res es esp pi pira ra ati i ion on a a are e e direct and cel ell l l au au a to to tono no n mo mo mous s s, , , an an a HDL levels may further improve muscular function we investigated whether age-induced decline in muscle performance is prevented in apoA-I tg mice. Endurance capacity was better maintained in aging apoA-I tg mice than wt mice ( Figure 3F ). Thus, HDL and apoA-I appear to play a role in the preservation of muscle function during aging by directly enhancing glucose utilization in skeletal muscle.
Raising HDL levels decreases fat mass in association with reduced circulating FGF21 levels and enhanced FFA release from white adipose tissue
To address whether HDL-enhanced muscular metabolism also results in a leaner phenotype, we monitored body composition of apoA-I tg and wt mice for 10 months: Age-induced increases in fat mass did not occur in apoA-I tg mice. Sedentary apoA-I tg mice retained a remarkably stable fat mass throughout their life span ( Figure 4A ). To understand whether the observed difference in fat mass is similar to that induced by chronic physical activity, we compared fat mass of sedentary apoA-I tg mice to that of apoA-I tg and wt mice subjected to daily aerobic exercise training throughout the study. As shown in Figure 4A , sedentary apoA-I tg mice exhibit fat mass values close to the levels of running mice. These results suggest that raising HDL levels under sedentary conditions may lead to a leaner phenotype that seems metabolically more similar to a physical active condition.
Fibroblast growth factor 21 (FGF21), a novel biomarker for mitochondrial deficiencies 31 , is increased in patients with the metabolic syndrome and correlates inversely with circulating HDL levels in humans and monkeys 32, 33 . We measured FGF21 levels in sedentary apoA-I tg and wt mice as an additional indicator of improved mitochondrial function. Both, hepatic expression and circulating levels of FGF21, were significantly lower in apoA-I tg mice compared to wt mice ( Figure 4B & C) . We propose that enhanced muscular mitochondrial function in apoA-I tg mice fat mass did not occur in apoA-I tg mice. Sedentary apoA-I tg mice retained a re ema ma mark rk r ab ab ably ly ly s s sta ta t b ble fat mass throughout their life span ( Figure 4A ). To understand whether the observed difference n n f f fat at at m m mas as ss s s i is is sim m mil il ilar a to that induced by chronic p p phy hy ysical activity, , we w c com om ompared fat mass of e ede de ent n ary apoA oA A-I -I -t t tg m mi m c ce ce t t to o o th th that at o o of f ap ap a oA oA A-I t t tg and d w w wt m m mi ic ce e su su subj bje ec ct te ed d to to o d dai aily ly ly a a aer erob ob obic ic ic e exe xe xer rc rcis s ise r rai ai aini ni ning ng ng t thr hr rou ou ough ghou ou out t th th he e st st s ud u y. y. y. A A As s s sh sh show ow wn n n in in in F Fi Figu gu gur re re 4 4A A A, , se se sed de dent nt ntar ar a y y y ap ap apoA oA A-I I I t tg g mi mi mice ce e e ex x xhib ib bit t t f fat at m m mas a s values close t to o o th th t e e e le le leve ve vels ls l o o of f f ru ru runn nn nnin in ing g g mi mi ice ce ce. . Th Th Thes es ese e re re esu su sult lts s s su su sugg gg gges es est t t th that at at r r rai ai aisi si sing ng ng H H HDL DL DL l l lev ev evel e s under 11 is reflected by lower circulating FGF21 levels. FGF21 is also known to inhibit lipolysis in white adipose tissue 34, 35 . To understand whether the reduction of fat mass may be partly due to an increase in fatty acid release from white adipose tissue we analyzed fasting free fatty acid (FFA).
As shown in Figure 4D , we found that FFA levels were increased in apoA-I tg mice compared to wt mice, indicating that lipolysis in white adipose tissue is enhanced. Consequently, FGF21-mediated inhibition of lipolysis may be reduced in apoA-I tg mice.
Raising HDL protects against diet-induced hyperglycemia through increased glucose utilization
To investigate the therapeutic potential of HDL in metabolic disease, we fed age-matched male apoA-I tg and wt mice HFD for 12 weeks and analyzed body composition and whole body glucose homeostasis. Although raising circulating HDL levels did not protect against dietinduced obesity ( Figure 5A & B) , fasting glucose levels were significantly lower in apoA-I tg mice compared to wt mice throughout the HFD feeding study ( Figure 5C ). This difference was even increased compared to the difference observed when mice were fed chow diet (data not shown). HbA1c levels were slightly reduced in apoA-I tg mice compared to wt mice (3.8 ± 0.2 vs 4.2 ± 0.08 %, n = 8). Mice of either group developed fasting hyperinsulinemia to the same extent ( Figure 5D ). However, GTT revealed that raising HDL levels improves the development of diet-induced impairment of glucose homeostasis ( Figure 5E ) independently of body-weight gain and diet-induced hyperinsulinemia.
Discussion
The present studies establish that circulating HDL is required for normal glucose homeostasis in skeletal muscle. We show that apoA-I directly increases glucose utilization by enhancing cellular apoA-I tg and wt mice HFD for 12 weeks and analyzed body composition and wh wh hol ol le bo bo body dy dy glucose homeostasis. Although raising circulating HDL levels did not protect against diet- 16 showed that selectively extracting cholesterol from the plasma membrane using methyl beta-cyclodextrin had no effect on AMPK phosphorylation in C2C12 myotubes, indicating that cholesterol efflux itself does not affect AMPK phosphorylation in skeletal muscle. However, HDL and apoA-I may also mediate their effect on glucose uptake through alternative pathways to ABCA1 signaling.
Accordingly, Han and colleagues provided in vitro evidence that endocytosis of apoA-I through the clathrin-dependent pathway is required for apoA-I-mediated AMPK and ACC activation 16 .
HDL has been also shown to transport and deliver endogenous microRNAs to recipient cells with functional gene regulatory consequences 36 . ApoA-I may also co-localize with lipid droplets and mitochondria within the skeletal muscle cell 37 , further strengthening the hypothesis that apoA-I acts intracellularly besides through its known surface receptors. Thus, although there is eported that the actions of HDL and apoA-I on glucose uptake occur through a re r rece ce ept pt tor o or--mediated event involving ABCA1, an ABC class of transporter. The authors suggested that, in f ad ddi di diti ti tion on on t t to o o m me medi iat at ati in ing reverse cholesterol transpor or ort, HDL also init tia ia i tes s a a a c c calcium-sensitive i i ign n nal a ing casc cad ad de e th thro ro oug ug gh h h AB AB ABC CA CA1. 1. 1 C Co on onsisten en ent wi i ith h h tho ho os se se f f fin in ndi din n ngs s s, H Ha a an e et t al al al. . 1 16 16 s sho ho howe we wed th th that at at e ele le lect ct tiv iv ivel ely y y ex ex extr tra ac cti i ing ng g c ch ho hole lest st ter erol ol ol f f fro ro rom m th h he e e p p plas as sma ma ma m m mem m mbr br bra an ane e us us u i in ing g g me me meth h hyl yl y b b bet et ta-a-a cy cy cyc cl clod d dex x xtr trin in n h h had a no effect on A A AMP MP MPK K K ph ph phos o o ph ph hor or oryl yl lat at atio io i n n n in n n C C C2C 2C 2C12 12 12 m m myo yo yotu tu t be be es, s, s, i i ind nd ndic ic icat at a in n ng g g th th that at at c c cho ho h le le lest st ster er erol ol ol e efflux itself f f an overnight starvation period. In contrast, we did not detect differences in glycogen content in muscle of apoA-I ko or apoA-I tg mice compared to wt mice. We think that this discrepancy may arise due to different experimental conditions. Our animals experiments did not include a fasting period and may therefore better portray the state of normal intracellular glycogen content.
Our in vitro results determining that glycolysis rates in skeletal muscle are markedly increased by HDL and apoA-I were confirmed by our in vivo findings that fasting lactate levels were significantly higher in mice with genetically raised HDL and apoA-I levels. One explanation for this observation is that at the point when glycogen stores in skeletal muscle have 
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http://circ.ahajournals.org/ Downloaded from glycogen by the so-called "indirect pathway of glycogen synthesis" to preserve this energy for the future 20 . Our findings that lactate levels are increased in apoA-I tg mice suggest that this may enhance the Cori cycle and allow lactate released by skeletal muscle to be used for oxidation but also for anabolic purposes by all tissues. According to this hypothesis, the lactate taken up would then be converted to pyruvate, a precursor for acetyl-CoA, which has many important anabolic functions 20 . In light of our observation that apoA-I tg mice exhibit a lower age-induced decline in muscle performance compared to age-matched wt mice, we conclude that the endurance capacity may be better preserved partially through an increased flux through the Cori cycle in addition to the enhancement in glucose oxidation. Simultaneously, HDL particles also increase glucose uptake in cultured adipocytes via a mechanism involving GLUT 4 translocation and AMPK activation 38 . Since adipose tissue releases significant amounts of lactate 39 , our observations that fasting lactate levels were increased and fat mass was reduced in apoA-I tg mice may be in part due to adipocytes not completely utilizing the glucose taken up, but instead releasing it as lactate which then serves as a substrate in the Cori cycle for anabolic processes in other tissues. This conclusion is supported by a leaner body composition of apoA-I tg mice. In contrast to data provided by Ruan et al 40 , we show that apoA-I tg mice are not protected against diet-induced obesity. Although the initial difference in fat mass disappeared after 12 weeks on HFD, apoA-I tg mice exhibited markedly lower glucose levels and better glucose tolerance than wt mice, indicating that raising HDL levels may offer a potential therapeutic option for obese and insulin-resistant patients who do not respond to weight-reducing measures.
Our studies furthermore may provide some intriguing insights into the inverse relationship of circulating HDL and FGF21 levels. A recent multi-center study showed that also increase glucose uptake in cultured adipocytes via a mechanism involving G GL GLUT UT UT 4 4 4 ranslocation and AMPK activation 38 . Since adipose tissue releases significant amounts of a act ct tat at ate e e 39 39 39 , ou ou o r r r ob bse se serv rvations that fasting lactate le e eve ve v l ls s were increase se ed an an nd d d f fat mass was reduced in ap po oA A-I tg mice ce m m ma ay ay b b be e in in in p p pa ar art t t du due e e t to to a a ad di ipoc cy cyt t tes n n no ot t com om ompl pl let etel ely y ut t til iliz izin in i g g g th th he e e g gl gluc uc cos os o e e e ta ta ake ke ken n up up up, , bu ut t t in in nst st stea ead d d re re rele lea as sin n ng g i it t a a as s la l ct ct ctat at te e e wh wh whic ich h h th th then en en s ser er erv ve es es a as s a su su sub b bstr tr trat at a e e e in in n t the he e C C Cor ori i i cy cy ycl cle e e f fo for r an an nab abo o olic c c processes in o o oth th ther er r t t tis is issu su ues e e . Th Th This i i c c con on o cl cl c us s sio io i n n n is is is s s sup up uppo po port rt rted ed b b by y y a a a le le ean an aner er b b bod od ody y y co co comp mp mpos os osit it i io io ion n n of apoA-I measuring circulating FGF21 concentrations reliably identified primary respiratory chain deficiencies in skeletal muscle of humans. The authors report that circulating FGF21 levels are about 10-fold increased in patients with mitochondrial disorders compared to healthy individuals and their data suggest that FGF21 induction is triggered by primary respiratory chain deficiencies 31 . Based on our findings presented herein we propose that FGF21 expression has been down-regulated by the improved mitochondrial function in apoA-I tg mice. FGF21 is also known to function as an inhibitor of lipolysis in mice, monkeys and human subjects [32] [33] [34] [35] 41 .
FGF21 is mainly expressed in the liver and thymus, and once secreted into circulation, it exerts its effects on adipose tissue like an endocrine hormone by binding its receptor -klotho 34 . Thus, our finding that FGF21 levels are reduced in apoA-I tg mice may point to an additional novel mechanism by which genetically raised HDL modulates lipolysis.
A number of intervention studies have shown that acute and long-term physical exercise have a clear beneficial effect on circulating HDL levels and on glucose tolerance in healthy subjects and in elderly, overweight and dyslipidemic patients [42] [43] [44] . Putting our findings into perspective, we propose that, besides its direct effects on glucose tolerance, physical activity may also enhance glucose oxidation indirectly by increasing HDL levels. Our rationale is supported by the finding that physical activity-induced increases in HDL levels correlate strongly with the up-regulation of gene expression sets for glycolysis and oxidative phosphorylation in physical active vs. inactive co-twins in a recently published Gene Set Enrichment Analysis 45 . Although the underlying mechanisms for the association between up-regulated skeletal muscle metabolic pathways and high circulating HDL levels in physical active subjects are largely unknown, it seems plausible that current therapeutic approaches to raise HDL levels may partly mimic exercise-mediated effects on glucose homeostasis. perspective, , w w we e e pr pr prop op opos os se e e th h hat at a , , , be be esi si side de es s s it t ts s s di di dire re rect ct ct e e eff ff f ec ec ects ts t o o on n n gl gl gluc uc u os os ose e e to o ole le lera ra ranc nc nce, e, e, p phy hy hysi si sica ca cal l l ac a tivity ma ay y by guest on July 25, 2017
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In conclusion, our studies show strong evidence that HDL and apoA-I are required for normal glucose homeostasis and muscle mitochondrial function. We provide evidence that the key HDL component apoA-I directly increases glucose utilization by enhancing cellular respiration in skeletal muscle cells. Furthermore, we demonstrate that genetically raising HDL levels leads to a reduction in fat mass in association with a decrease in circulating FGF21 levels.
Since low and dysfunctional HDL might contribute to the exacerbation of insulin resistance, therapeutic approaches to raise HDL levels and improve HDL function may not only benefit patients with cardiovascular disease but also improve metabolic diseases such as insulin resistance and T2D. . Data a a are r e exp xp xpr re ressed as means ± SEM d * *P P < < < 0.05; ** P P P < < < 0 0 0.0 0 005 0 0 , , ** ** *** * P P P P P < < 0 0 0.0 .0 .000 005 5 v vs. wt wt wt mi ic ce e e. P P P (n = 6-7 per group). Data are expressed as means ± SEM *P < 0.05; ***P < 0.0005 vs. wt mice. For the exercise study, mice were accustomed to treadmill running for 3 days as described previously 1 and then an exercise exhaustion test was performed in all mice. Next, mice were randomized for body weight and divided into two groups. The 'runner' group was subjected to treadmill running (Simplex II metabolic performed during the first four hours in the dark phase of the circadian cycle at weeks 0 and 8 of the study as described previously 1 . Briefly, animals ran on the treadmill tilted 20° uphill starting at a warm-up speed of 5 m/min for 4 min after which speed was increased to 14m/min for 2 min. Every subsequent 2 min, the speed was increased by 2 m/min until mice were exhausted. Exhaustion was defined as the inability of the animal to return to running within 10 s after direct contact with an electric-stimulus grid and/or terminal glucose levels below 100 mg/dl. Running time was measured and running distance calculated. Distance is the product of time and speed of the treadmill. Outside of the training schedule, all mice had unlimited access to food and water.
For the determination of downstream insulin-signaling target AKT we fasted mice for 2 hours prior to intraperitoneal injection of insulin (2 IU/kg body weight) or saline (equal volumes). 5 minutes after injection, mice were sacrificed by cervical dislocation, liver and quadiceps muscles were immediately harvested and snap frozen in liquid nitrogen for later determination of AKT phosphorylation.
Euglycemic-hyperinsulinemic clamp studies
Mice underwent vascular surgery under anesthesia with Isoflurane (1,5% ; Air : 0,4l/min) at least 6 days before the experiment. The right jugular vein was catheterized for infusion with a silastic catheter. The free end of the catheter was tunneled under the skin to the back of the neck. Catheters are flushed daily with ~50µl of 0,9% NaCl containing 5mg/ml ampicillin and 20U.I/ml heparin.After surgery animals were individually housed and their body weight was monitored daily. Mice that lost more than 10% of presurgery weight by postsurgery day 6 were excluded from the study. At the day of the clamp study, conscious mice were place in their home cage for the duration of the clamp experiment and fooddeprivated for 5 hours. After a bolus infusion of (5 µCi) of D-[3-3H] glucose (Perkin Elmer, Courtaboeuf, France) tracer solution and 80 mU/kg insulin, the tracer was infused continuously (0.05 µCi/min, at a constant rate of 1μl/min) for the duration of the experiment and insulin infusion was kept constant at 0,2UI/kg/h (3,33mU/kg/min). Blood glucose levels were determined from tail blood samples (1-2 μl) at t =0 and then every 20 min using the glucose analyzer Glucofix® (A. Menarini, Rungis, France). Steady state was ascertained when glucose measurements were constant for at least 20 min at a fixed glucose infusion rate and this was achieved within 50 to 80min. At steady state, 3 blood sample (10μl) were collected for determination of basal parameters, followed by a bolus injection of 2-deoxy- 
Biochemical Assays
individually except for lipoprotein separation in which pooled samples were subjected to fast-performance liquid chromatography (FPLC) as described previously Respiration studies in isolated skeletal muscle mitochondria and cultured muscle cells.
After sacrifice, gastrocnemius muscles were excised and mitochondria were isolated immediately as described previously 6 . For isolated muscle mitochondria all respiration measurements were made in triplicate and followed this protocol: resting respiration (state II, absence of adenylates) was assessed by the addition of 5 mM glutamate and 2 mM malate as the complex I supply. State III respiration was assessed by the addition of 1 mM ADP and subsequent state IV (uncoupling respiration) was determined by adding 2 uM of oligomycin. The integrity of the outer mitochondrial membrane was established by the addition of 10 uM cytochrome c. Measurements of oxygen consumption rate (OCR) by the Seahorse 24XF analyzer (Seahorse Biosciences Inc., North Billerica, MA) were completed within a 8-to 12-min period.
To investigate whether HDL directly enhances glycolysis via the extracellular acidification rate (ECAR) and/or mitochondrial oxygen consumption rate (OCR), murine skeletal muscle C2C12 cells were incubated for 4 hours with increasing amounts of human HDL and 4,5 mg/ml glucose utilizing the Seahorse XF24 analyzer as described previously 7 . To determine whether the observed effect on glycolysis is specifically mediated by HDL and/or its major protein constituent apoA-I, we incubated C2C12 cells with glucose (4,5 mg/ml) and with or without HDL, LDL, phospholipid vesicles (all at the same phospholipid concentration 100 ug/ml), and apoA-I (which was used at the same protein concentration as for HDL, 50 ug/ml) for 4 hours prior to determining glycolysis (ECAR). HDL, LDL, phospholipid vesicles and human apoA-I were prepared as described previously
8
.
Immuno blot analysis:
Whole gastrocnemius and quadriceps homogenates in lysis buffer from Pierce (Thermo open triangles) (n= 6-8). Data are expressed as means ± SEM ***P < 0.0005.
